Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Epharma AB
AB
Active
Org 5592525231
Apoteksvägen 82, 741 42
Knivsta
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2020 · 6 years old
10-19 employees
Overvåg
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Epharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
3M
4M
6M
0M
2021
2M
2022
3M
2023
5M
2024
4M
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
0M
2021
1M
+100%
2022
0M
-100%
2023
1M
+100%
2024
1M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
417
1 968
2 528
4 581
4 345
Staff expenses
—
−1 018
−2 215
−3 276
−2 546
EBITDA
231
864
75
732
779
Depreciation & amort.
−74
−74
−127
−95
−71
EBIT
157
790
−52
637
708
Net financials
−9
−4
−1
4
13
Profit before tax
110
589
2
641
539
Tax
−24
−122
−2
−133
−113
Net profit
86
467
0
508
426
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
564
1 439
969
1 489
2 114
Equity
111
578
579
1 087
1 213
Long-term debt
330
0
—
—
—
Short-term debt
85
626
211
222
538
Total debt
415
626
211
222
538
Financial ratios
5-year trend
EBITDA-margin
17.9%
This company
15.8%
Market median
+13% vs market
2021
2025
Soliditetsgrad
57.4%
This company
38.2%
Market median
+50% vs market
2021
2025
Egenkapitalforrentning
35.1%
This company
18.4%
Market median
+91% vs market
2021
2025
Nettoresultatgrad
9.8%
This company
8.1%
Market median
+21% vs market
2021
2025
Aktivomsætning
2.06×
This company
1.12×
Market median
+84% vs market
2021
2025
Gæld/egenkapital
0.74×
This company
0.62×
Market median
+19% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
More on Epharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
